XML 38 R24.htm IDEA: XBRL DOCUMENT

16. Subsequent Event (Notes)	12 Months Ended
16. Subsequent Event (Notes)	Dec. 31, 2015
16. Subsequent Event [Abstract]
Subsequent Events [Text Block]	16. SUBSEQUENT EVENT In January 2016, we acquired a high performance analytical flow cytometer platform from Propel Labs (Propel) that will enable advanced and novice users to perform basic and multi-parameter cytometry for a wide range of applications and chemistries. Bio-Rad expects to launch the instrument later this year. The aggregate consideration for the instrument consisted of a cash payment in January 2016 of $10.0 million, with payments of up to $20.0 million due upon the completion of certain technical milestones. Following the completion of these milestones, semi-annual performance payments to Propel will be required based on a percentage of sales through 2020. We are presently unable to report the purchase price allocation or the evaluation of the transaction, as more time is needed to complete the information transfer from the seller and include all information into a valuation of individual assets and liabilities, including contingent consideration.